Lates News

Citibank Group initiated coverage on GlaxoSmithKline for the first time, giving a "neutral" rating with a target price of 1900 pence; initiated coverage on Novo Nordisk for the first time, giving a "neutral" rating with a target price of 400 Danish krone.